Tarbox Family Office’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
PVH
WBG
KHLMVGHM
Tarbox Family Office's XPH Position: Q1 2016 in Review
Tarbox Family Office sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2016, closing a stake of 126 shares — an estimated $6K sold.
Tarbox Family Office first reported a position in XPH in Q1 2015 and held it in 4 quarters. The position peaked at $16K in Q2 2015. 71 funds tracked by Wall St. Rank hold XPH as of Q1 2016.
- Tarbox Family Office reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
- Tarbox Family Office sold 126 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2016, an estimated $6K.
- Tarbox Family Office first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2015 and held it in 4 quarters.
- Tarbox Family Office's State Street SPDR S&P Pharmaceuticals ETF position peaked at $16K in Q2 2015.
- 71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2016.
Based on Tarbox Family Office's 13F filing for Q1 2016, filed 27 Apr 2016.